Caricamento...
Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome
BACKGROUND: Macrophage activation syndrome (MAS) is a potentially fatal complication of systemic inflammation. HMGB1 is a nuclear protein released extracellularly during proinflammatory lytic cell death or secreted by activated macrophages, NK cells, and additional cell types during infection or ste...
Salvato in:
| Pubblicato in: | Mol Med |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8111379/ https://ncbi.nlm.nih.gov/pubmed/33975537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10020-021-00308-0 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|